2010
DOI: 10.1007/s00432-010-0795-x
|View full text |Cite
|
Sign up to set email alerts
|

Expression of TRF1, TRF2, TIN2, TERT, KU70, and BRCA1 proteins is associated with telomere shortening and may contribute to multistage carcinogenesis of gastric cancer

Abstract: Our results suggest that the over-expression of telomeric proteins, TRF1, TRF2, TIN2, TERT, and Ku70, and the transposition of the BRCA1 protein may work together to reduce the telomere length in precancerous lesions and gastric cancer, and could contribute to the multistage carcinogenesis of gastric cancer. These findings offer new insight into the mechanism of carcinogenesis in gastric cancer.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

8
49
0
2

Year Published

2010
2010
2022
2022

Publication Types

Select...
7
1
1

Relationship

1
8

Authors

Journals

citations
Cited by 63 publications
(59 citation statements)
references
References 34 publications
8
49
0
2
Order By: Relevance
“…These findings indicate an interaction between positive and negative factors in the maintenance of TL in plasma cell disorders and support a role for TRF2 and TANK1 upregulation in disease progression. In a related study of gastric cancer, a significantly higher expression of TRF2 in tumor tissue and in lymph-node metastasis compared with precancerous lesions and normal gastric mucosa was found (28). Changes in telomeric gene expression and their negative correlations with telomere reduction, observed in our series, suggest that mechanisms other than telomerase activation are involved in TL maintenance in plasma cell disorders.…”
Section: Discussionsupporting
confidence: 62%
“…These findings indicate an interaction between positive and negative factors in the maintenance of TL in plasma cell disorders and support a role for TRF2 and TANK1 upregulation in disease progression. In a related study of gastric cancer, a significantly higher expression of TRF2 in tumor tissue and in lymph-node metastasis compared with precancerous lesions and normal gastric mucosa was found (28). Changes in telomeric gene expression and their negative correlations with telomere reduction, observed in our series, suggest that mechanisms other than telomerase activation are involved in TL maintenance in plasma cell disorders.…”
Section: Discussionsupporting
confidence: 62%
“…Therefore, it was hypothesized that high or low protein expression may induce instability of shelterin, which may lead to the occurrence of malignant tumors. In a previous study by the present authors, it was detected that TIN2 protein expression was higher in the precancerous lesion, gastric cancer and metastasis groups compared with the normal group (18). Furthermore, the expression of TIN2 protein was higher in the gastric cancer and metastasis groups compared with the precancerous group (18).…”
Section: Introductionsupporting
confidence: 52%
“…In a previous study by the present authors, it was detected that TIN2 protein expression was higher in the precancerous lesion, gastric cancer and metastasis groups compared with the normal group (18). Furthermore, the expression of TIN2 protein was higher in the gastric cancer and metastasis groups compared with the precancerous group (18). Therefore, it was hypothesized that abnormal TIN2 expression may induce shelterin instability, thereby leading to the occurrence of malignant tumors.…”
Section: Introductionmentioning
confidence: 45%
“…We were particularly interested in CDX2, CDKN2A, RUNX3, FOXO4, PPARG, BRCA1 and PML because they had been shown to play negative roles in GC proliferation and growth. [18][19][20][21][22][23][24] To verify the effects of methylation changes on the expression of these genes, we examined the methylation status of the promoter regions using methylation-specific PCR in MKN45 cells transfected with shUHRF1, SGC7901 cells with UHRF1 and their negative controls. As shown in Figure 4A, UHRF1 inhibition reversed the promoter methylation of all these genes and upregulation of UHRF1 enhanced promoter methylation.…”
Section: Tumor Suppressors Contribute To Uhrf1-induced Growth Inhibitionmentioning
confidence: 99%